|
|
||||||||
ORIGINAL PAPER |
CRC Department of Epithelial Biology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Manchester, United Kingdom
Key Words. Intestinal stem cells • Clonogenic cells • Radiation • 5-Fluorouracil • Survival time
Dr. C.S. Potten, CRC Department of Epithelial Biology, Paterson Institute for Cancer Research, Christie Hospital NHS Trust, Wilmslow Road, Manchester, M20 9BX, United Kingdom.
The effect of administering recombinant human interleukin 11 in conjunction with cytotoxic insults to the gastrointestinal tract has been studied using the crypt microcolony assay for stem cell function and whole-animal survival time studies. The cytotoxic regimens include single doses of
Three doses of 5-FU 6 h apart generated crypt survival curves similar to those obtained after a single dose of
rays; single doses of 5-fluorouracil (5-FU) and multiple doses of 5-FU spaced 6 h apart. Interleukin 11 (IL-11) (100 µg/kg) delivered over a period of time prior to cytotoxic exposure afforded protection to the clonogenic cells in the crypts as seen with the microcolony assay and prolonged the animal survival time following radiation exposure. Continuing this dose of IL-11 after cytotoxic exposure afforded little additional protection.
rays. IL-11 given prior to two doses of 5-FU effectively abolished the cytotoxic effect of the second dose of 5-FU; i.e., 2.5-3.0 times more crypts survived if IL-11 was administered when the higher 5-FU doses are considered. IL-11 given before a dose of 12 Gy of
rays prolonged the survival time of animals by three to four days. This confirms earlier studies demonstrating that protecting clonogenic cells in the crypt survival assay can result in beneficial effects on whole-animal survival times.
This article has been cited by other articles:
![]() |
N. M. Ramocki, H. R. Wilkins, S. T. Magness, J. G. Simmons, B. P. Scull, G. H. Lee, K. K. McNaughton, and P. K. Lund Insulin Receptor Substrate-1 Deficiency Promotes Apoptosis in the Putative Intestinal Crypt Stem Cell Region, Limits Apcmin/+ Tumors, and Regulates Sox9 Endocrinology, January 1, 2008; 149(1): 261 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Boerma, J. Wang, A. F. Burnett, A. D. Santin, J. J. Roman, and M. Hauer-Jensen Local Administration of Interleukin-11 Ameliorates Intestinal Radiation Injury in Rats Cancer Res., October 1, 2007; 67(19): 9501 - 9506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kiessling, G. Muller-Newen, S. N. Leeb, M. Hausmann, H. C. Rath, J. Strater, T. Spottl, K. Schlottmann, J. Grossmann, F. A. Montero-Julian, et al. Functional Expression of the Interleukin-11 Receptor {alpha}-Chain and Evidence of Antiapoptotic Effects in Human Colonic Epithelial Cells J. Biol. Chem., March 12, 2004; 279(11): 10304 - 10315. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. E. Riehl, R. D. Newberry, R. G. Lorenz, and W. F. Stenson TNFR1 mediates the radioprotective effects of lipopolysaccharide in the mouse intestine Am J Physiol Gastrointest Liver Physiol, January 1, 2004; 286(1): G166 - G173. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Booth and C. S. Potten Protection Against Mucosal Injury By Growth Factors and Cytokines J Natl Cancer Inst Monographs, October 1, 2001; 2001(29): 16 - 20. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
